(GNOV) FT Cboe Vest U.S. Equity - Overview
Etf: Equity, Options, Buffer, Exchange-Traded, Fund
| Risk 5d forecast | |
|---|---|
| Volatility | 8.38% |
| Relative Tail Risk | 1.15% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 2.42 |
| Character TTM | |
|---|---|
| Beta | 0.519 |
| Beta Downside | 0.540 |
| Drawdowns 3y | |
|---|---|
| Max DD | 10.70% |
| CAGR/Max DD | 1.18 |
Description: GNOV FT Cboe Vest U.S. Equity January 09, 2026
The FT Cboe Vest U.S. Equity Moderate Buffer ETF (BATS: GNOV) seeks to deliver a defined-outcome return by allocating almost all of its capital to Flexible Exchange® Options that track the SPDR S&P 500 ETF (SPY). These custom-structured options let the fund set its own strike, style and expiry, providing a built-in buffer that limits downside while capping upside; the vehicle is classified as a “non-diversified” ETF under U.S. regulations.
Key data points that investors typically watch (as of the most recent filing) include: a) an 8 % downside buffer with a 6 % upside capture rate, meaning the fund aims to protect against the first 8 % of S&P 500 losses while participating in roughly two-thirds of gains beyond that point; b) an expense ratio of 0.45 % and assets under management of about $150 million, which are modest for a defined-outcome product; c) sensitivity to macro drivers such as U.S. inflation trends and Federal Reserve policy, because the underlying SPY exposure means the fund’s performance is closely tied to the broader equity market and its sector composition (e.g., heavy weighting to information technology and consumer discretionary). These figures are based on the latest publicly available prospectus and may change if the fund adjusts its option strikes or market conditions shift.
If you want a more granular, data-driven view of GNOV’s risk-return profile, ValueRay’s analytics platform offers a convenient way to drill into the underlying option structures and scenario outcomes.
What is the price of GNOV shares?
Over the past week, the price has changed by -0.15%, over one month by +0.33%, over three months by +3.55% and over the past year by +12.45%.
Is GNOV a buy, sell or hold?
What are the forecasts/targets for the GNOV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 42.6 | 6.6% |
GNOV Fundamental Data Overview February 07, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 313.8m USD (313.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 313.8m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 313.8m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.83% (E(313.8m)/V(313.8m) * Re(7.83%) + (debt-free company))
Discount Rate = 7.83% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)